Cove Private Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Cove Private Wealth's PFE Position: Q3 2026 in Review
Cove Private Wealth increased its Pfizer (PFE) stake by 0.29% in Q3 2026, buying an estimated $6.46K and bringing the position to 84,575 shares worth $2.41M. The position accounts for 0.42% of the portfolio, ranked #44.
Cove Private Wealth first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.45M in Q4 2024. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Cove Private Wealth held 84,575 shares of Pfizer worth $2.41M as of Q3 2026.
- Cove Private Wealth bought 243 Pfizer shares in Q3 2026, an estimated $6.46K.
- Pfizer made up 0.42% of Cove Private Wealth's portfolio in Q3 2026, its #44 holding.
- Cove Private Wealth first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
- Cove Private Wealth's Pfizer position peaked at $2.45M in Q4 2024.
- 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Cove Private Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.